 Sheera Rosenbaum
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 10 | 2024 | 757 | 1.950 |
Why?
| | SOXE Transcription Factors | 3 | 2024 | 18 | 1.040 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 124 | 0.930 |
Why?
| | Skin Neoplasms | 8 | 2022 | 842 | 0.930 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2025 | 188 | 0.800 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 427 | 0.760 |
Why?
| | NF-kappa B | 1 | 2025 | 691 | 0.720 |
Why?
| | B7 Antigens | 1 | 2020 | 14 | 0.670 |
Why?
| | Forkhead Transcription Factors | 1 | 2020 | 183 | 0.620 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 174 | 0.610 |
Why?
| | Genes, Essential | 1 | 2017 | 22 | 0.580 |
Why?
| | Cell Line, Tumor | 11 | 2025 | 3185 | 0.530 |
Why?
| | Cell Proliferation | 4 | 2021 | 2381 | 0.510 |
Why?
| | Neoplasms | 2 | 2021 | 2467 | 0.460 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2025 | 1341 | 0.430 |
Why?
| | Proto-Oncogene Proteins B-raf | 5 | 2022 | 214 | 0.350 |
Why?
| | Mice, Inbred NOD | 2 | 2021 | 586 | 0.310 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 209 | 0.310 |
Why?
| | Receptor, ErbB-3 | 2 | 2015 | 45 | 0.240 |
Why?
| | Neuregulin-1 | 2 | 2015 | 46 | 0.240 |
Why?
| | Immunotherapy | 2 | 2021 | 599 | 0.230 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 615 | 0.200 |
Why?
| | Cell Death | 1 | 2024 | 353 | 0.200 |
Why?
| | Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2021 | 6 | 0.190 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 42 | 0.190 |
Why?
| | Signal Transduction | 4 | 2025 | 4930 | 0.190 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5365 | 0.190 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
| | Medulloblastoma | 1 | 2023 | 197 | 0.190 |
Why?
| | Mice | 3 | 2025 | 16832 | 0.180 |
Why?
| | Mice, SCID | 1 | 2021 | 349 | 0.180 |
Why?
| | Tumor Burden | 1 | 2021 | 285 | 0.180 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 177 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 229 | 0.170 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 616 | 0.170 |
Why?
| | Cell Adhesion Molecule-1 | 1 | 2019 | 1 | 0.160 |
Why?
| | Twist-Related Protein 1 | 1 | 2019 | 8 | 0.160 |
Why?
| | Aminopyridines | 1 | 2019 | 96 | 0.160 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 111 | 0.160 |
Why?
| | Antigens, CD | 1 | 2021 | 483 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2024 | 1210 | 0.150 |
Why?
| | Pyrroles | 1 | 2019 | 204 | 0.150 |
Why?
| | GTP Phosphohydrolases | 2 | 2015 | 79 | 0.150 |
Why?
| | Nuclear Proteins | 2 | 2023 | 652 | 0.150 |
Why?
| | Humans | 13 | 2025 | 130305 | 0.150 |
Why?
| | Animals | 4 | 2025 | 35076 | 0.140 |
Why?
| | Survival Analysis | 1 | 2020 | 1293 | 0.130 |
Why?
| | Cytokines | 1 | 2024 | 2016 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 842 | 0.120 |
Why?
| | Immunologic Factors | 1 | 2017 | 232 | 0.120 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2015 | 55 | 0.120 |
Why?
| | Epidermal Growth Factor | 1 | 2015 | 171 | 0.120 |
Why?
| | Running | 1 | 2017 | 229 | 0.120 |
Why?
| | Proteins | 1 | 2019 | 948 | 0.110 |
Why?
| | B7-H1 Antigen | 1 | 2015 | 186 | 0.110 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 315 | 0.110 |
Why?
| | Receptor, ErbB-2 | 1 | 2015 | 337 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2015 | 398 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2015 | 1121 | 0.100 |
Why?
| | RNA, Messenger | 1 | 2020 | 2732 | 0.100 |
Why?
| | Macrophages | 1 | 2019 | 1482 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1928 | 0.090 |
Why?
| | Cell Movement | 1 | 2015 | 948 | 0.090 |
Why?
| | Fibroblasts | 1 | 2015 | 953 | 0.090 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7128 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 431 | 0.070 |
Why?
| | Male | 3 | 2021 | 63748 | 0.060 |
Why?
| | Female | 2 | 2025 | 68842 | 0.060 |
Why?
| | Tyrosine | 1 | 2023 | 220 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 160 | 0.050 |
Why?
| | Sequence Analysis, DNA | 2 | 2015 | 780 | 0.050 |
Why?
| | Aged | 1 | 2020 | 22282 | 0.040 |
Why?
| | Mutation | 3 | 2015 | 3723 | 0.040 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 14 | 0.040 |
Why?
| | Tissue Array Analysis | 1 | 2019 | 57 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 66 | 0.040 |
Why?
| | Middle Aged | 1 | 2020 | 31322 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 484 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2019 | 197 | 0.030 |
Why?
| | Adult | 1 | 2020 | 35711 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 910 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2519 | 0.030 |
Why?
| | Cyclin B1 | 1 | 2015 | 7 | 0.030 |
Why?
| | Syk Kinase | 1 | 2015 | 21 | 0.030 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2015 | 19 | 0.030 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2015 | 76 | 0.030 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2015 | 71 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 226 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1207 | 0.030 |
Why?
| | Exome | 1 | 2015 | 220 | 0.030 |
Why?
| | Immune System | 1 | 2015 | 176 | 0.030 |
Why?
| | RNA Interference | 1 | 2015 | 453 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3084 | 0.030 |
Why?
| | Ligands | 1 | 2015 | 624 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 311 | 0.030 |
Why?
| | Down-Regulation | 1 | 2015 | 642 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 586 | 0.030 |
Why?
| | Collagen | 1 | 2015 | 437 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1201 | 0.030 |
Why?
| | Indoles | 1 | 2015 | 379 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 389 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1196 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 856 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1314 | 0.020 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2015 | 429 | 0.020 |
Why?
| | Cell Survival | 1 | 2015 | 1098 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1107 | 0.020 |
Why?
| | Sulfonamides | 1 | 2015 | 502 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1711 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3830 | 0.020 |
Why?
| | Skin | 1 | 2015 | 742 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2015 | 763 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1714 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10341 | 0.020 |
Why?
| | Child | 1 | 2023 | 20961 | 0.010 |
Why?
|
|
Rosenbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|